Kala Pharmaceuticals

Band of biotechs cut pipeline prospects to focus cash on priority programs
Fierce Biotech
Thu, 08/11/22 - 11:30 pm
ProQR Therapeutics
Harpoon Therapeutics
Kala Pharmaceuticals
Synthetic Biologics
AcelRx to Buy Lowell Therapeutics; Kala Expands Pipeline with Combangio Acquisition
BioSpace
Tue, 11/16/21 - 10:37 pm
AcelRx
Kala Pharmaceuticals
M&A
Lowell Therapeutics
Combangio
Unmet Need in Dry Eye Disease Market Leaves Room for Other Drugmakers to Step In
BioSpace
Fri, 11/13/20 - 12:49 pm
dry eye disease
Novartis
Allergan
Sun Pharma
Bausch
Kala Pharmaceuticals
Kala Gets the Greenlight from FDA for Dry Eye Disease Treatment
BioSpace
Tue, 10/27/20 - 11:30 pm
Kala Pharmaceuticals
FDA
Eysuvis
dry eye disease
Go or no go? Vaccine panel upstages US approval decisions
EP Vantage
Fri, 10/2/20 - 12:44 pm
FDA
vaccines
COVID-19
advisory panel
Eysuvis
Brilinta
Kala Pharmaceuticals
dry eye disease
Regeneron
AstraZeneca
stroke
Upcoming events – Axsome takes on migraine and Kala looks to dry eye again
EP Vantage
Sun, 11/10/19 - 07:58 pm
Axsome Therapeutics
migraines
AXS-07
Kala Pharmaceuticals
clinical trials
KP-121
dry eye disease
FDA wants additional data on Kala Pharma’s KPI-121
Pharma Letter
Fri, 08/9/19 - 10:43 am
Kala Pharmaceuticals
KP-121
dry eye disease
FDA
Go or no go? Abbvie, Roche and Kala await key decisions
EP Vantage
Fri, 07/26/19 - 11:04 am
FDA
AbbVie
upadacatinib
Roche
Ignyta
entrectinib
Kala Pharmaceuticals
KPI-121
dry eye disease
FDA sets summer PDUFA dates for Acer, Kala therapies
BioCentury
Fri, 12/28/18 - 01:16 pm
FDA
Acer Therapeutics
Kala Pharmaceuticals
Edsivo celiprolol
KPI-121
Kala seeks FDA nod for dry eye disease drug
Drug Delivery Business News
Tue, 10/16/18 - 11:34 am
Kala Pharmaceuticals
FDA
KPI-121
dry eye disease
FDA approves Kala's twice-daily ocular steriod
BioCentury
Fri, 08/24/18 - 11:18 am
Kala Pharmaceuticals
Inveltys
ocular steriods
eye health
Kala Pharma reveals mixed Ph3 data for dry eye disease drug
Drug Delivery Business News
Fri, 01/5/18 - 05:29 pm
Kala Pharmaceuticals
dry eye disease
KPI-121
Kala Pharmaceuticals prices $90m IPO
Drug Delivery Business News
Thu, 07/20/17 - 06:00 pm
Kala Pharmaceuticals
IPOs
cataract surgery
FierceBiotech's 2013 Fierce 15
Fierce Biotech
Wed, 09/25/13 - 01:04 pm
biotech
AnaptysBio
Acetylon Pharmaceuticals
CytomX
Immunocore
FibroGen
Jounce Therapeutics
Kala Pharmaceuticals
Macrogenics
Moderna Therapeutics
Presage Biosciences
Nimbus Discovery
Scioderm
Ultragenyx
uniQure
Visterra
Kala Pharmaceuticals Co-founder Publishes Data on Novel Therapeutic Approach to Overcome Mucosal Barrier for Prevention of Herpes Simplex Virus-2 Infection
PharmaLive
Sun, 07/15/12 - 12:18 pm
Kala Pharmaceuticals
herpes
herpes simplex 2